Conditions of License. As a material condition of the license granted in this Section 5.1, CFFTI shall, and shall require any of its sublicensees to provide the Company with copies of any clinical data that the Company does not already have, which results from testing, use or sale of the Products in North America, within [********] of the receipt of such data by CFFTI or its sublicensee, and throughout the term of this license, the Company shall provide CFFTI with [******************************], use, or sale of the Products outside of North America, and in North America, if the sublicense granted under Section 5.2 is in effect, within sixty days of the preparation or receipt of such data by the Company or its sublicensee.
Appears in 4 contracts
Samples: Strategic Alliance Agreement (Altus Pharmaceuticals Inc.), Strategic Alliance Agreement (Altus Pharmaceuticals Inc.), Strategic Alliance Agreement (Altus Pharmaceuticals Inc.)
